candesartan cilexetil has been researched along with B16 Melanoma in 1 studies
candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Egami, K | 1 |
| Murohara, T | 1 |
| Shimada, T | 1 |
| Sasaki, K | 1 |
| Shintani, S | 1 |
| Sugaya, T | 1 |
| Ishii, M | 1 |
| Akagi, T | 1 |
| Ikeda, H | 1 |
| Matsuishi, T | 1 |
| Imaizumi, T | 1 |
1 other study available for candesartan cilexetil and B16 Melanoma
| Article | Year |
|---|---|
Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth.
Topics: Animals; Benzimidazoles; Biphenyl Compounds; Cyclohexanes; Endothelial Growth Factors; Intercellular | 2003 |